Crescent Biopharma, Inc.CBIONASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+51.0%
5Y CAGR+21.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+51.0%/yr
vs -2.0%/yr prior
5Y CAGR
+21.5%/yr
Recent acceleration
Acceleration
+53.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $163.39M | +137.6% |
| 2024 | $68.76M | +75.0% |
| 2023 | $39.29M | -17.3% |
| 2022 | $47.48M | -26.5% |
| 2021 | $64.61M | +4.8% |
| 2020 | $61.67M | +0.5% |
| 2019 | $61.39M | +19.2% |
| 2018 | $51.51M | +53.0% |
| 2017 | $33.67M | +5.4% |
| 2016 | $31.93M | - |